Carrie Wade
      OUR PEOPLE

      Dr. Carrie Wade

      Doctorate in Pharmacology and Neuroscience

      Senior Manager Global Scientific Engagement

      Contact

      Carrie is Senior Manager Global Scientific Engagement. She currently leads a team to facilitate scientific engagement with global public health experts and to share the science behind PMI’s smoke-free products. She holds a Doctorate in Pharmacology and Neuroscience from the University of Minnesota and a master’s degree in Public Health from John Hopkins University, Bloomberg School of Public Health.   

      Carrie has many years of experience studying neural mechanisms of opioid addiction (University of Minnesota and Scripps Research) and public health interventions to address adverse outcomes related to addiction (John Hopkins University and Baltimore Harm Reduction Coalition). Before joining PMI, she led the Harm Reduction Policy team at the R Street Institute in Washington, D.C., focusing on barriers to access tobacco and opioid harm reduction and protection of sexual health. She has published numerous studies in international scientific journals and book chapters, and articles in the media. 

      Latest Publications

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.